Evaluation of the highly sensitized transplant recipient

Pediatric Nephrology

Volumn 26, Issue 11, 2011, Pages 1927-1935

  Stastny, Peter ^a   Salvador, Ian Michael ^b   Lavingia, Bhavna ^b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Antibodies; Crossmatches; Endothelial cell antigens; HLA antigens; Panel reactive antibodies; Single HLA antigen Luminex beads

Indexed keywords

ALLOANTIGEN; ANTIBODY; AUTOANTIGEN; DONOR SPECIFIC ANTIBODY; HLA ANTIBODY; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ANALYSIS; B LYMPHOCYTE; CELL MEDIATED CYTOTOXICITY; CELLULAR IMMUNITY; DESENSITIZATION; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSPOT ASSAY; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL PROCEDURES; KIDNEY DONOR; MOLECULAR TYPING; PRIORITY JOURNAL; REVIEW; SENSITIZATION; T LYMPHOCYTE; TECHNIQUE; TREATMENT FAILURE; UMBILICAL VEIN ENDOTHELIAL CELL; VIRTUAL CROSSMATCH;

DESENSITIZATION, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HUMANS; MALE; TRANSPLANTATION IMMUNOLOGY;

EID: 83155190186     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-010-1732-6     Document Type: Review

References (32)

1. Sanfilippo F, Vaughn WK, Bollinger RR, Spees EK (1982) Comparative effects of pregnancy, transfusion, and prior graft rejection on sensitization and renal transplant results. Transplantation 34:360-366 (Pubitemid 13170996)
2. Kissmeyer-Nielsen F, Olsen S, Petersen VP, Fjeldborg O (1966) Hyperacute rejection of kidney allografts, associated with preexisting humoral antibodies against donor cells. Lancet 2:662-665
3. Patel R, Terasaki PI (1969) Significance of the positive crossmatch test in kidney transplantation. N Engl J Med 280:735-739
4. Moraes JR, Stastny P (1977) A new antigen system expressed in human endothelial cells. J Clin Invest 60:449-454 (Pubitemid 8154153)
5. Win TS, Pettigrew GJ (2010) Humoral autoimmunity and transplant vasculopathy: when allo is not enough. Transplantation 90:113-120
6. Pei R, Lee JH, Shih NJ, Chen M, Terasaki PI (2003) Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 75:43-49 (Pubitemid 36139693)
7. Waanders MM, Heidt S, Koekkoek KM, Zoet YM, Doxiadis II, Amir A, Heemskerk MH, Mulder A, Brand A, Roelen DL, Claas FH, Ward FE, MacQueen JM, Amos DB, Delmas-Marsalet Y, Johnson A (2008) Monitoring of indirect allorecognition: wishful thinking or solid data? The antiglobulin microcytotoxicity assay in HL-A genotyped families. Tissue Antigens 71:1-15
8. Ward FE, MacQueen JM, Amos DB, Delmas-Marsalet Y, Johnson A (1975) The antiglobulin microcytotoxicity assay in HL-A genotyped families. Transplantation 19:286-290
9. Karpinski M, Rush D, Jeffery J, Exner M, Regele H, Dancea S, Pochinco D, Birk P, Nickerson P (2001) Flow cytometric crossmatching in primary renal transplant recipients with a negative anti-human globulin enhanced cytotoxicity crossmatch. J Am Soc Nephrol 12:2807-2814 (Pubitemid 33115429)
10. El-Awar N, Lee J, Terasaki PI (2005) HLA antibody identification with single antigen beads compared to conventional methods. Hum Immunol 66:989-997 (Pubitemid 41790535)
11. SEOPF (1993) Southeastern organ procurement foundation tissue typing manual. Section B-20:12-13
12. Rebibou JM, Chabod J, Bittencourt MC, Thevenin C, Chalopin JM, Herve P, Tiberghien P (2000) Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation. Transplant Proc 32:2745-2746 (Pubitemid 32008221)
13. Cecka JM (2009) Calculated PRA (CPRA): the new measure of sensitization for transplant candidates. Am J Transplant 10:26-29
14. Amos DB, Bach FH (1968) Phenotypic expressions of the major histocompatibility locus in man (HL-A): leukocyte antigens and mixed leukocyte culture reactivity. J Exp Med 128:623-637
15. Grunnet N, Kristensen T, Kornerup HJ, Kissmeyer-Nielsen F (1975) Direct cell mediated lympholysis. A test of allograftrejection in human kidney recipients. Tissue Antigens 5:280-285
16. Poggio ED, Heeger PS (2004) Use of cytokine enzyme-linked immunosorbent spot (ELISPOT) assay as an immune monitoring tool in solid organ transplantation. Transplant Rev 18:183-191 (Pubitemid 39650919)
17. Gupta S, Mitchell JD, Markham DW, Mammen PP, Patel PC, Kaiser PA, Stastny P, Ring WS, Dimaio JM, Drazner MH (2008) Utility of the cylex assay in cardiac transplant recipients. J Heart Lung Transplant 27:817-822
18. Stastny P, Lavingia B, Fixler DE, Yancy CW, Ring WS (2007) Antibodies against donor human leukocyte antigens and the outcome of cardiac allografts in adults and children. Transplantation 84:738-745 (Pubitemid 47480659)
19. Everly MJ, Rebellato LM, Ozawa M, Briley KP, Catrou PG, Haisch CE, Terasaki PI (2010) Beyond histology: lowering human leukocyte antigen antibody to improve renal allograft survival in acute rejection. Transplantation 89:962-967
20. Lobo PI, Isaacs RB, Spencer CE, Pruett TL, Sanfey HA, Sawyer RG, McCullough C (2002) Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation. Transpl Int 15:563-569 (Pubitemid 36061729)
21. Lefaucheur C, Suberbielle-Boissel C, Hill GS, Nochy D, Andrade J, Antoine C, Gautreau C, Charron D, Glotz D (2009) Clinical relevance of preformed HLA donor-specific antibodies in kidney transplantation. Contrib Nephrol 162:1-12
22. Hidalgo LG, Campbell PM, Sis B, Einecke G, Mengel M, Chang J, Sellares J, Reeve J, Halloran PF (2009) De novo donor-specific antibody at the time of kidney transplant biopsy associates with microvascular pathology and late graft failure. Am J Transplant 9:2532-2541
23. Lefaucheur C, Loupy A, Hill GS, Andrade J, Nochy D, Antoine C, Gautreau C, Charron D, Glotz D, Suberbielle-Boissel C (1398) Preexisting donor-specific HLA antibodies predict outcome in kidney transplantation. J Am Soc Nephrol 21:1398-1406
24. Muczynski KA, Ekle DM, Coder DM, Anderson SK (2003) Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol 14:1336-1348 (Pubitemid 36514674)
25. Opelz G (2005) Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies. Lancet 365:1570-1576 (Pubitemid 40615406)
26. Lavingia B, Qin Z, Comeaux A, Stastny P (2008) Correlation of antibodies against endothelial cell antigens with outcome of kidney regrafts. Hum Immunol 69:S108-S109
27. Lavingia B, Comeaux A, Qin Z, Stastny P (2009) Anti-endothelial cell antibodies correlate with the development of TCAD in heart transplant recipients. Hum Immunol 70:S85
28. Bell SA, Faust H, Mittermuller J, Kolb HJ, Meurer M (1996) Specificity of antinuclear antibodies in scleroderma-like chronic graft-versus-host disease: clinical correlation and histocompatibility locus antigen association. Br J Dermatol 134:848-854 (Pubitemid 26151399)
29. Hirata D, Iwamoto M, Yoshio T, Okazaki H, Masuyama J, Mimori A, Minota S (2000) Nucleolin as the earliest target molecule of autoantibodies produced in MRL/lpr lupus-prone mice. Clin Immunol 97:50-58
30. Fogal V, Sugahara KN, Ruoslahti E, Christian S (2009) Cell surface nucleolin antagonist causes endothelial cell apoptosis and normalization of tumor vasculature. Angiogenesis 12:91-100
31. Mizutani K, Terasaki P, Rosen A, Esquenazi V, Miller J, Shih RN, Pei R, Ozawa M, Lee J (2005) Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure. Am J Transplant 5:2265-2272 (Pubitemid 41648475)
32. Lee PC, Zhu L, Terasaki PI, Everly MJ (2009) HLA-specific antibodies developed in the first year posttransplant are predictive of chronic rejection and renal graft loss. Transplantation 88:568-574